Results 11 to 20 of about 108,588 (220)
Burden of visceral leishmaniasis in villages of eastern gedaref state, Sudan: an exhaustive cross-sectional survey. [PDF]
, 2012 Since December 2009, Médecins Sans Frontières has diagnosed and treated patients with visceral leishmaniasis (VL) in Tabarak Allah Hospital, eastern Gedaref State, one of the main endemic foci of VL in Sudan.
A Ismail +37 more
core +27 more sources
Clinical Medicine, 2011 Leishmaniasis is an uncommon infectious disease in the UK with a variety of clinical presentations. Physicians should remember to consider this diagnosis in patients with an appropriate travel history (including the Mediterranean basin) and seek help with diagnostics from a specialised parasitology laboratory.
Elinor M, Moore, Diana N, Lockwood
openaire +5 more sources
Indian Journal of Critical Care Medicine, 2021 Leishmaniasis is one of the chronic debilitating vector-borne diseases caused by obligate intracellular protozoa. The global burden of disease although not increasing but potential risk of spread is there. At least 20 species of Leishmania are pathogenic to human beings. The transmission is from female sandfly through a blood meal.
Daga, Mradul K +2 more
openaire +3 more sources
Leishmaniasis: new approaches to disease control. [PDF]
, 2003 The leishmaniases afflict the world's poorest populations. Among the two million new cases each year in the 88 countries where the disease is endemic (fig 1), it is estimated that 80% earn less than $2 a day.
Croft, Simon L +3 more
core +2 more sources
Postgraduate Medical Journal, 2006 Abstract Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity
Tonio V, Piscopo +1 more
openaire +4 more sources
Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. [PDF]
, 2011 Due to unacceptably high mortality with pentavalent antimonials, Médecins Sans Frontières in 2006 began using liposomal amphotericin B (AmBisome) for visceral leishmaniasis (VL) patients in Ethiopia who were severely ill or positive for human ...
Aderie, Endashaw Mengistu +6 more
core +2 more sources
hautnah dermatologie, 2015 ZusammenfassungInfektionen mit Leishmanien gehören zu den Top 3 der häufigsten Reisedermatosen. Je nach Reiseland und Immunstatus des Patienten unterscheiden sich die Krankheitsbilder. Die Infektion bildet sich in 90 % der Fälle als kutane Leishmaniasis aus, kann sich aber auch an den inneren Organen manifestieren (viszerale Leishmaniasis).
openaire +4 more sources
Journal of Tropical Medicine, 2013 Visceral leishmaniasis (VL) is a parasitic disease characterized by immune suppression. Successful treatment is usually followed by immune reconstitution and a dermatosis called post-Kala-azar dermal leishmaniasis (PKDL).
Eltahir Awad Gasim Khalil +7 more
doaj +1 more source
The epidemiology of canine leishmaniasis: transmission rates estimated from a cohort study in Amazonian Brazil [PDF]
, 1997 We estimate the incidence rate, serological conversion rate and basic case reproduction number (R0) of Leishmania infantum from a cohort study of 126 domestic dogs exposed to natural infection rates over 2 years on Marajó Island, Pará State, Brazil.
Courtenay, O. +3 more
core +1 more source